Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

From fertility enhancement programs in the Himalayas to brain bootcamps in Switzerland, these wellness experiences are ...

It seems imagination is the only limit to AI-based protein design. But there's room for even more progress in 2025.

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

Researchers developed spatial aging clocks to map brain cell aging, revealing how T cells accelerate aging and NSCs ...

A study reveals how brain cell interactions influence aging, showing that rare cell types either accelerate or slow brain aging.